503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
17.37%
Net income growth at 50-75% of BB's 24.08%. Martin Whitman would worry about lagging competitiveness unless expansions are planned.
-5.14%
Negative yoy D&A while BB is 10.69%. Joel Greenblatt would note a short-term EPS advantage unless competitor invests for future advantage.
-115.33%
Both lines show negative yoy. Martin Whitman would see an industry or cyclical factor reducing tax deferrals for both players.
6.49%
SBC growth of 6.49% while BB is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
143.11%
Well above BB's 75.06% if positive yoy. Michael Burry would see a risk of bigger working capital demands vs. competitor, harming free cash flow.
250.99%
AR growth of 250.99% while BB is zero at 0.00%. Bruce Berkowitz would see a mild difference in credit approach that could matter for cash flow.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-107.01%
Negative yoy usage while BB is 67.57%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-81.69%
Both negative yoy, with BB at -236.53%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
59.00%
Operating cash flow growth at 50-75% of BB's 105.73%. Martin Whitman would worry about lagging operational liquidity vs. competitor.
49.83%
CapEx growth well above BB's 34.51%. Michael Burry would suspect heavier cash outlays that risk short-term free cash flow vs. competitor.
4.88%
Acquisition growth of 4.88% while BB is zero at 0.00%. Bruce Berkowitz sees a mild outflow that must deliver synergy to justify the difference.
26.36%
Purchases well above BB's 16.14%. Michael Burry would see major cash outflow into securities vs. competitor’s approach, risking near-term FCF.
18.71%
At 50-75% of BB's 35.42%. Martin Whitman questions partial disadvantage if competitor monetizes investments more efficiently.
100.00%
Growth well above BB's 100.00%. Michael Burry would suspect heavier intangible or side spending overshadowing competitor’s approach, risking short-term FCF.
84.74%
Investing outflow well above BB's 44.99%. Michael Burry sees possible short-term FCF risk unless these invests pay off quickly vs. competitor’s approach.
78.06%
Debt repayment growth of 78.06% while BB is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
73.43%
Lower share issuance yoy vs. BB's 428.72%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
-6900.00%
We cut yoy buybacks while BB is 0.00%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.